Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration ...

Australia's Therapeutic Goods Administration (TGA) recently issued a safety alert requiring extra warnings to be included ...

Spravato is now the first-ever stand-alone therapy for treatment-resistant depression, and is on its way to becoming a ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

The most common type of medication for postpartum depression is antidepressants. These drugs can help relieve many of the symptoms of depression, but they take time — typically 6 to 8 weeks ...

Here are some common drugs that can cause dizziness ... muscle relaxants, and other drugs. Used for: Depression and anxiety. Examples: Fluoxetine (Prozac) and trazodone (Desyrel).

The largest, most ethnically diverse, study of its kind has flagged hundreds of genetic variants that play a role in ...

The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.

The FDA has approved esketamine (Spravato) nasal spray as a monotherapy for adults with treatment-resistant depression. This ...

Doctors should think twice before prescribing drug therapies when faced with someone battling depression, as exercise may be more effective, according to a new study. A meta-analysis of 218 ...